Post study drug access to BMS investigational medicinal products and approved products

In certain situations, patients who have participated in a BMS Clinical Trial may require access to the BMS study drug used in the trial post study if the drug is not reasonably available.

Submitting a request form

We welcome requests for Post Study Drug Access from the Investigators who treated these patients. Request forms must be submitted by the healthcare professional.  Patient eligibility will be determined by Bristol Myers Squibb in accordance with established policies and procedures. Bristol Myers Squibb’s acceptance and processing of this application does not guarantee that access to the drug product will be provided.

Post study drug access requests

Click here to submit a new patient request.